General Information of the Compound
| Compound ID |
CP0244546
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[8-amino-3-[(1R,3S)-3-(1-methyltetrazol-5-yl)cyclohexyl]imidazo[1,5-a]pyrazin-1-yl]-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H25F3N10O
|
||||||||||||||||||
| Molecular Weight |
562.56
|
||||||||||||||||||
| Canonical SMILES |
Cn1nnnc1[C@H]1CCC[C@H](C1)c1nc(-c2ccc(cc2)C(=O)Nc2cc(ccn2)C(F)(F)F)c2c(N)nccn12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H25F3N10O/c1-39-25(36-37-38-39)18-4-2-3-17(13-18)24-35-21(22-23(31)33-11-12-40(22)24)15-5-7-16(8-6-15)26(41)34-20-14-19(9-10-32-20)27(28,29)30/h5-12,14,17-18H,2-4,13H2,1H3,(H2,31,33)(H,32,34,41)/t17-,18+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LFBCSUBLJDFNLB-MSOLQXFVSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound